Skip to content
Triangle logo TriangleGet started
← Full study record

NCT03245736 · BASELINE

Baseline characteristics

Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors. · Source last updated 2021-11-04

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      5
    units
    Participants
groups
  1. description
    Tisotumab vedotin was administered as an intravenous (IV) infusion on Day 1 of each 21-day cycle (once every 3 weeks). The trial ran until the investigator determined that the participant was no longer benefiting from treatment (ie, disease progression or unacceptable toxicity had occurred), the trial was terminated by the sponsor, or the participant withdrew consent. Each participant received the same dose that they were exposed to in the previous base trial.
    id
    BG000
    title
    Tisotumab Vedotin
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          10.46
          spread
          10.46
          value
          50.4
    dispersion Type
    STANDARD_DEVIATION
    param Type
    GEOMETRIC_MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        title
        In utero
      2. measurements
        1. group Id
          BG000
          value
          0
        title
        Preterm newborn infants (gestational age < 37 wks)
      3. measurements
        1. group Id
          BG000
          value
          0
        title
        Newborns (0-27 days)
      4. measurements
        1. group Id
          BG000
          value
          0
        title
        Infants and toddlers (28 days-23 months)
      5. measurements
        1. group Id
          BG000
          value
          0
        title
        Children (2-11 years)
      6. measurements
        1. group Id
          BG000
          value
          0
        title
        Adolescents (12-17 years)
      7. measurements
        1. group Id
          BG000
          value
          5
        title
        Adults (18-64 years)
      8. measurements
        1. group Id
          BG000
          value
          0
        title
        From 65-84 years
      9. measurements
        1. group Id
          BG000
          value
          0
        title
        85 years and over
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Age, Customized
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          5
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          0
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        title
        American Indian or Alaska Native
      2. measurements
        1. group Id
          BG000
          value
          0
        title
        Asian
      3. measurements
        1. group Id
          BG000
          value
          0
        title
        Native Hawaiian or Other Pacific Islander
      4. measurements
        1. group Id
          BG000
          value
          0
        title
        Black or African American
      5. measurements
        1. group Id
          BG000
          value
          5
        title
        White
      6. measurements
        1. group Id
          BG000
          value
          0
        title
        More than one race
      7. measurements
        1. group Id
          BG000
          value
          0
        title
        Unknown or Not Reported
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Race (NIH/OMB)
    unit Of Measure
    Participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      5
    units
    Participants
groups
  1. description
    Tisotumab vedotin was administered as an intravenous (IV) infusion on Day 1 of each 21-day cycle (once every 3 weeks). The trial ran until the investigator determined that the participant was no longer benefiting from treatment (ie, disease progression or unacceptable toxicity had occurred), the trial was terminated by the sponsor, or the participant withdrew consent. Each participant received the same dose that they were exposed to in the previous base trial.
    id
    BG000
    title
    Tisotumab Vedotin
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          10.46
          spread
          10.46
          value
          50.4
    dispersion Type
    STANDARD_DEVIATION
    param Type
    GEOMETRIC_MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        title
        In utero
      2. measurements
        1. group Id
          BG000
          value
          0
        title
        Preterm newborn infants (gestational age < 37 wks)
      3. measurements
        1. group Id
          BG000
          value
          0
        title
        Newborns (0-27 days)
      4. measurements
        1. group Id
          BG000
          value
          0
        title
        Infants and toddlers (28 days-23 months)
      5. measurements
        1. group Id
          BG000
          value
          0
        title
        Children (2-11 years)
      6. measurements
        1. group Id
          BG000
          value
          0
        title
        Adolescents (12-17 years)
      7. measurements
        1. group Id
          BG000
          value
          5
        title
        Adults (18-64 years)
      8. measurements
        1. group Id
          BG000
          value
          0
        title
        From 65-84 years
      9. measurements
        1. group Id
          BG000
          value
          0
        title
        85 years and over
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Age, Customized
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          5
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          0
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        title
        American Indian or Alaska Native
      2. measurements
        1. group Id
          BG000
          value
          0
        title
        Asian
      3. measurements
        1. group Id
          BG000
          value
          0
        title
        Native Hawaiian or Other Pacific Islander
      4. measurements
        1. group Id
          BG000
          value
          0
        title
        Black or African American
      5. measurements
        1. group Id
          BG000
          value
          5
        title
        White
      6. measurements
        1. group Id
          BG000
          value
          0
        title
        More than one race
      7. measurements
        1. group Id
          BG000
          value
          0
        title
        Unknown or Not Reported
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Race (NIH/OMB)
    unit Of Measure
    Participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice